Mayo Clinic, Department of Clinical Genomics, Rochester, MN, USA; Metabolomics Expertise Center, CCB, KU Leuven-VIB, Leuven, Belgium; Laboratory of Hepatology, Department of CHROMETA, KU Leuven, Leuven, Belgium.
Tulane University Medical School, New Orleans, LA, USA.
Mol Genet Metab. 2021 Jan;132(1):27-37. doi: 10.1016/j.ymgme.2020.10.007. Epub 2020 Oct 17.
Pathogenic alterations in the DPM2 gene have been previously described in patients with hypotonia, progressive muscle weakness, absent psychomotor development, intractable seizures, and early death. We identified biallelic DPM2 variants in a 23-year-old male with truncal hypotonia, hypertonicity, congenital heart defects, intellectual disability, and generalized muscle wasting. His clinical presentation was much less severe than that of the three previously described patients. This is the second report on this ultra-rare disorder. Here we review the characteristics of previously reported individuals with a defect in the DPM complex while expanding the clinical phenotype of DPM2-Congenital Disorders of Glycosylation. In addition, we offer further insights into the pathomechanism of DPM2-CDG disorder by introducing glycomics and lipidomics analysis.
先前在患有张力减退、进行性肌肉无力、精神运动发育迟缓、难治性癫痫发作和早逝的患者中描述了 DPM2 基因的致病性改变。我们在一名 23 岁的男性中鉴定出 DPM2 基因的双等位基因突变,该男性患有躯干张力减退、肌肉紧张、先天性心脏缺陷、智力残疾和全身性肌肉萎缩。他的临床表现比之前描述的三名患者要轻得多。这是关于这种超罕见疾病的第二份报告。在这里,我们回顾了 DPM 复合物缺陷患者的特征,同时扩展了 DPM2-先天性糖基化障碍的临床表型。此外,我们通过引入糖组学和脂质组学分析,为 DPM2-CDG 疾病的病理机制提供了进一步的见解。